연구동향 분석
박사

스텐트시술 초기에 나타는 재협착을 치료하기 위한 유전자가 내장되어있는 동맥 스텐트 : Gene-embedded coronary stent for treatment of post-angioplasty restenosis

차혜련 2015년

논문상세정보
인용/피인용
' 스텐트시술 초기에 나타는 재협착을 치료하기 위한 유전자가 내장되어있는 동맥 스텐트 : Gene-embedded coronary stent for treatment of post-angioplasty restenosis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • akt1 sirna
  • gene delivery
  • microrna 145
  • restenosis
  • stent
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
81 0

0.0%

' 스텐트시술 초기에 나타는 재협착을 치료하기 위한 유전자가 내장되어있는 동맥 스텐트 : Gene-embedded coronary stent for treatment of post-angioplasty restenosis' 의 참고문헌

  • You I, Kang SM, Byun Y, Lee H. Enhancement of blood compatibility of poly(urethane)substrates by mussel-inspired adhesive heparin coating. Bioconjug Chem;22(7):1264-1269.
  • Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb VascBiol. 2002;22:1769-76.
  • Wang K, Kessler PD, Zhou Z, et al. Local adenoviral-mediated inducible nitric oxidesynthase gene transfer inhibits neointimal formation in the porcine coronary stented model.Mol Ther. 2003;7(5 Pt 1):597-603.
  • Walter DH, Cejna M, Diaz-Sandoval L, et al. Local gene transfer of phVEGF-2 plasmid bygene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation.2004;110:36-45.49
  • Travis JA, Hughes MG, Wong JM, et al. Hyaluronan enhances contraction of collagen bysmooth muscle cells and adventitial fibroblasts: Role of CD44 and implications for constrictive48remodeling. Circ Res. 2001;88:77-83.
  • Travis JA, Hughes MG, Wong JM, Wagner WD, Geary RL. Hyaluronan enhancescontraction of collagen by smooth muscle cells and adventitial fibroblasts - role of CD44 andimplications for constrictive remodeling. Circ Res. 2001;88:77-83.
  • Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis aftercoronary stenting. N Engl J Med. 1997;336:1697-703.
  • Sharif F, Hynes SO, Cooney R, et al. Gene-eluting stents: adenovirus-mediated delivery ofeNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis. MolTher. 2008;16:1674-80.
  • Segura T, Volk MJ, Shea LD. Substrate-mediated DNA delivery: role of the cationicpolymer structure and extent of modification. Journal of Controlled Release. 2003;93:69-84.
  • Segura T, Volk MJ, Shea LD. Substrate-mediated DNA delivery: role of the cationicpolymer structure and extent of modification. J Control Release. 2003;93:69-84.
  • Scott NA. Restenosis following implantation of bare metal coronary stents: Pathophysiologyand pathways involved in the vascular response to injury. Adv Drug Deliv Rev. 2006;58:358-76.
  • Riessen R, Wight TN, Pastore C, et al. Distribution of hyaluronan during extracellularmatrix remodeling in human restenotic arteries and balloon- injured rat carotid arteries.Circulation. 1996;93:1141-7.
  • Remuzzi A, Mantero S, Colombo M, et al. Vascular smooth muscle cells on hyaluronicacid: culture and mechanical characterization of an engineered vascular construct. Tissue Eng.2004;10:699-710.
  • Remuzzi A, Mantero S, Colombo M, Morigi M, Binda E, Camozzi D, et al. Vascular smoothmuscle cells on hyaluronic acid: culture and mechanical characterization of an engineeredvascular construct. Tissue Eng. 2004;10:699-710.
  • Nakatani M, Takeyama Y, Shibata M, et al. Mechanisms of restenosis after coronaryintervention: difference between plain old balloon angioplasty and stenting. Cardiovasc Pathol.2003;12:40-8.
  • Muhs A, Heublein B, Schletter J, et al. Preclinical evaluation of inducible nitric oxidesynthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesionformation. Hum Gene Ther. 2003;14:375-83.
  • Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: aserial intravascular ultrasound study. Circulation. 1996;94:35-43.
  • Miano JM, Vlasic N, Tota RR, et al. Localization of Fos and Jun proteins in rat aorticsmooth muscle cells after vascular injury. Am J Pathol. 1993;142:715-24.
  • Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis:classification and implications for long-term outcome. Circulation. 1999;100:1872-8.
  • Luo D, Saltzman WM. Enhancement of transfection by physical concentration of DNA atthe cell surface. Nat Biotechnol. 2000;18:893-5.
  • Liu MW, Roubin GS, King SB, 3rd. Restenosis after coronary angioplasty. Potentialbiologic determinants and role of intimal hyperplasia. Circulation. 1989;79:1374-87.
  • Lee Y, Lee H, Kim YB, Kim J, Hyeon T, Park H, et al. Bioinspired Surface Immobilizationof Hyaluronic Acid on Monodisperse Magnetite Nanocrystals for Targeted Cancer Imaging.Adv Mater 2008;20(21):4154-4157.
  • Lee H, Dellatore SM, Miller WM, Messersmith PB. Mussel-inspired surface chemistry formultifunctional coatings. Science 2007;318(5849):426-430.
  • Koo H, Jin GW, Kang H, Lee Y, Nam K, Zhe Bai C, et al. Biodegradable branchedpoly(ethylenimine sulfide) for gene delivery. Biomaterials. 2010;31:988-97.
  • Kim TG, Lee Y, Park TG. Controlled gene-eluting metal stent fabricated by bio-inspiredsurface modification with hyaluronic acid and deposition of DNA/PEI polyplexes. Int J Pharm.2010;384:181-8.
  • Jiang HL, Xu CX, Kim YK, Arote R, Jere D, Lim HT, et al. The suppression of lungtumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNAcomplexes through the Akt signaling pathway. Biomaterials. 2009;30:5844-52.
  • Jiang HL, Hong SH, Kim YK, Islam MA, Kim HJ, Choi YJ, et al. Aerosol delivery ofspermine-based poly(amino ester)/Akt1 shRNA complexes for lung cancer gene therapy. Int J50Pharm. 2011;420:256-65.
  • Jere D, Jiang HL, Kim YK, Arote R, Choi YJ, Yun CH, et al. Chitosan-graftpolyethyleniminefor Akt1 siRNA delivery to lung cancer cells. Int J Pharm. 2009;378:194-200.
  • Jere D, Arote R, Jiang HL, Kim YK, Cho MH, Cho CS. Biodegradable nano-polymericsystem for efficient Akt1 siRNA delivery. J Nanosci Nanotechnol. 2010;10:3366-9.
  • Indolfi C, Torella D, Coppola C, et al. Rat carotid artery dilation by PTC balloon catheterinduces neointima formation in presence of IEL rupture. Am J Physiol Heart Circ Physiol.2002;283:H760-H767.
  • Indolfi C, Coppola C, Torella D, et al. Gene therapy for restenosis after balloon angioplastyand stenting. Cardiol Rev. 1999;7:324-31.
  • Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis.A serial intravascular ultrasound study. Circulation. 1996;94:1247-54.47
  • Heublein B, Evagorou EG, Rohde R, et al. Polymerized degradable hyaluronan-- a platformfor stent coating with inherent inhibitory effects on neointimal formation in a porcine coronarymodel. Int J Artif Organs. 2002;25:1166-73.
  • Heublein B, Evagorou EG, Rohde R, Ohse S, Meliss RR, Barlach S, et al. Polymerizeddegradable hyaluronan - a platform for stent coating with inherent inhibitory effects onneointimal formation in a porcine coronary model. Int J Artif Organs. 2002;25:1166-73.
  • Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of humanatherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-5.
  • Gilles MA, Hudson AQ, Borders CL, Jr. Stability of water-soluble carbodiimides in51aqueous solution. Anal Biochem. 1990;184:244-8.
  • Fishbein I, Alferiev IS, Nyanguile O, et al. Bisphosphonate-mediated gene vector deliveryfrom the metal surfaces of stents. Proc Natl Acad Sci U S A. 2006;103:159-64.
  • Fishbein I, Alferiev IS, Nyanguile O, Gaster R, Vohs JM, Wong GS, et al. Bisphosphonatemediatedgene vector delivery from the metal surfaces of stents. Proc Natl Acad Sci USA.2006;103:159-64.
  • Fishbein I, Alferiev I, Bakay M, et al. Local delivery of gene vectors from bare-metal stentsby use of a biodegradable synthetic complex inhibits in-stent restenosis in rat carotid arteries.Circulation. 2008;117:2096-103.
  • Farb A, Weber DK, Kolodgie FD, et al. Morphological predictors of restenosis aftercoronary stenting in humans. Circulation. 2002;105:2974-80.
  • Farb A, Kolodgie FD, Hwang JY, et al. Extracellular matrix changes in stented humancoronary arteries. Circulation. 2004;110:940-7.
  • Duguay D, deBlois D. Differential regulation of Akt, caspases and MAP kinases underliessmooth muscle cell apoptosis during aortic remodelling in SHR treated with amlodipine. Br JPharmacol. 2007;151:1315-23.
  • Dangas G, Fuster V. Management of restenosis after coronary intervention. Am Heart J.1996 ;132(2 Pt 1):428-36.
  • Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation.2005;111:2257-73.
  • Califf RM, Fortin DF, Frid DJ, Harlan WR, 3rd, Ohman EM, Bengtson JR, et al. Restenosisafter coronary angioplasty: an overview. J Am Coll Cardiol. 1991;17:2B-13B.
  • Boussif O, Lezoualch F, Zanta MA, Mergny MD, Scherman D, Demeneix B, et al. Aversatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo -polyethylenimine. P Natl Acad Sci USA. 1995;92:7297-301.
  • Bengali Z, Rea JC, Shea LD. Gene expression and internalization following vectoradsorption to immobilized proteins: dependence on protein identity and density. J Gene Med.2007;9:668-78.
  • Bengali Z, Rea JC, Gibly RF, Shea LD. Efficacy of immobilized polyplexes and lipoplexesfor substrate-mediated gene delivery. Biotechnol Bioeng. 2009;102:1679-91.
  • Bengali Z, Pannier AK, Segura T, Anderson BC, Jang JH, Mustoe TA, et al. Gene deliverythrough cell culture substrate adsorbed DNA complexes. Biotechnol Bioeng. 2005;90:290-302.